Obesity Drug
-
{
- All
- News
- Videos
-
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
Researchers found that combining semaglutide with regular exercise led to greater fat loss and better overall results than using the medication alone.
-
Popular Weight Loss Drug Wegovy Linked To Rare Blinding Eye Condition, Finds Study
The study does not say that Wegovy directly causes blindness. Instead, researchers found a strong link between the drug and a condition called ischemic optic neuropathy.
-
More Weight Loss While On Ozempic Means Lower Risk Of Obesity-Related Diseases, Says New Study
The new analysis suggests that greater weight loss achieved while taking Ozempic and similar GLP-1 medications may lead to a larger reduction in obesity-related disease risk.
-
Your Genes May Decide How Well Weight Loss Drugs Work: Study
The research suggested that some of the same gene variants associated with better weight loss were also linked to stronger gastrointestinal side effects such as nausea or vomiting.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
Weight Loss Drugs May Impact Brain's Reward Centre, Study Warns
Newer oral weight loss drugs could be doing more than only suppressing appetite -- they may also be directly altering brain circuits that control motivation and reward, according to a new study.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
On Ozempic Or Wegovy? Doctors Say Stop Before Surgery, Here's Why
The ASA guidance suggests that patients on GLP-1 drugs should consult their healthcare providers well in advance of any planned surgery.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
Weight Loss Drugs May Be Making Patients Lose More Than Just Fat
UNC researchers found popular incretin drugs like semaglutide and tirzepatide are linked to unusually high muscle loss during weight loss.
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
-
Taking Ozempic? New Study Explains Why Pairing It With Exercise Is Important For Your Muscles
Researchers found that combining semaglutide with regular exercise led to greater fat loss and better overall results than using the medication alone.
-
Popular Weight Loss Drug Wegovy Linked To Rare Blinding Eye Condition, Finds Study
The study does not say that Wegovy directly causes blindness. Instead, researchers found a strong link between the drug and a condition called ischemic optic neuropathy.
-
More Weight Loss While On Ozempic Means Lower Risk Of Obesity-Related Diseases, Says New Study
The new analysis suggests that greater weight loss achieved while taking Ozempic and similar GLP-1 medications may lead to a larger reduction in obesity-related disease risk.
-
Your Genes May Decide How Well Weight Loss Drugs Work: Study
The research suggested that some of the same gene variants associated with better weight loss were also linked to stronger gastrointestinal side effects such as nausea or vomiting.
-
Wegovy Pill Users Lost Up To 21.6% Weight In New Obesity Trial
The findings come from Novo Nordisk's phase 3 OASIS 4 clinical trial studying oral semaglutide 25 mg, the same active ingredient used in injectable Wegovy.
-
Weight Loss Drugs May Impact Brain's Reward Centre, Study Warns
Newer oral weight loss drugs could be doing more than only suppressing appetite -- they may also be directly altering brain circuits that control motivation and reward, according to a new study.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Fake Mounjaro Worth Rs 56 Lakh Seized In Gurugram: What It Can Do To Your Body
Fake Mounjaro injections seized in Gurugram highlight rising counterfeit weight-loss drug risks and severe health dangers.
-
On Ozempic Or Wegovy? Doctors Say Stop Before Surgery, Here's Why
The ASA guidance suggests that patients on GLP-1 drugs should consult their healthcare providers well in advance of any planned surgery.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
Weight Loss Drugs May Be Making Patients Lose More Than Just Fat
UNC researchers found popular incretin drugs like semaglutide and tirzepatide are linked to unusually high muscle loss during weight loss.
-
From Ozempic To Bariatric Surgery, Delhi Doctor Ranks 7 Weight-Loss Methods
Not everyone can or should opt for Ozempic, Mounjaro, or bariatric surgery for weight loss. The doctor lists seven methods and explains who they suit best
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
